MassDevice15d
FDA clears revision knee implant from Zimmer Biomet
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.
Hosted on MSN3mon
Zimmer Biomet’s total shoulder replacement system gains FDA 510(k) clearance
a component of its total knee implant system. "Zimmer Biomet’s total shoulder replacement system gains FDA 510(k) clearance" was originally created and published by Medical Device Network ...
Becker's Spine Review9d
Zimmer Biomet plans 3 more Rosa robotic indications
Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...
Yahoo Finance12d
FDA grants 510(k) clearance to Zimmer’s new revision knee implant component
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision ... “We are proud to offer a total revision knee construct with no deliberate addition ...
Longview News-Journal16d
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur
Knees at Zimmer Biomet. "We are proud to offer a total revision knee construct with no deliberate addition of the most common metal allergens (Nickel, Cobalt, & Chromium). Metal sensitivity is one ...
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTion™ Femur, a ...